RT Journal Article
SR Electronic
T1 Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.141113
DO 10.3899/jrheum.141113
A1 Lilian H.  van Tuyl
A1 Martina Sadlonova
A1 Bev Davis
A1 Caroline Flurey
A1 Niti Goel
A1 Sarah E.  Hewlett
A1 Catherine L.  Hill
A1 Wijnanda Hoogland
A1 John R.  Kirwan
A1 Dirkjan van Schaardenburg
A1 Marieke Scholte-Voshaar
A1 Josef S.  Smolen
A1 Tanja Stamm
A1 George A.  Wells
A1 Maarten Boers
YR 2015
UL http://www.jrheum.org/content/early/2015/02/10/jrheum.141113.abstract
AB Objective The treatment of rheumatoid arthritis (RA) should target patient-relevant outcomes, making patient perspective on remission essential. In 2010, patients, physicians, health professionals, and researchers at the Outcome Measures in Rheumatology (OMERACT) conference developed an ambitious research agenda to study the concept of remission. Qualitative research has since helped us understand the concept of remission from the patient perspective. Methods During OMERACT 12, the OMERACT working group on patient perspective on remission in RA elaborated on data generated to date and discussed the methodological challenges ahead. Challenges included (1) selection of domains, (2) choice of a patient remission definition or a single domain to add to the current remission definition, and (3) the importance of pain in defining remission from a patient perspective. Results Focus in the coming years will be on increasing our understanding by identifying the most important domains from the patient perspective regarding remission and investigating how these domains can be measured. Investigation into the Rheumatoid Arthritis Impact of Disease questionnaire, disease flare, as well as the concordance of domains from our ongoing remission survey is appropriate. More data and further discussions are needed to decide on the next steps. Conclusion Progress summarized over 4 years highlights the main methodological challenges discussed within the working group on patient perspective on remission in RA during OMERACT 12.